Pharma

Pharma

Alzheimer’s disease market to reach $12.9bn in 2028 driven by launch of new pipeline agents

Drug sales for Alzheimer’s disease (AD) and mild cognitive impairment (MCI) collectively reached $2.2bn in 2018 across the eight major markets (8MM*). By the end of the forecast period in 2028, these sales are forecast to increase to $12.9bn at a compound annual growth rate (CAGR) of 19.3%, according to GlobalData, a leading data and […]

Pharma

Favipiravir approval in India will benefit majority of COVID-19 patients, says GlobalData

Following the news that Glenmark Pharmaceuticals has become the first company in India to receive regulatory approval for oral antiviral favipiravir for the treatment of mild to moderate COVID-19; Prashant Khadayate, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view: “The approval of Glenmark’s ‘FabiFlu’ for emergency restricted use only by […]

Pharma

European COVID-19 clinical trials primarily focused on repurposing available therapies, says GlobalData

The phase distribution of clinical trials in Europe suggests that sponsors are focusing primarily on repurposing available therapies to treat COVID-19 and that the level of research directly correlates with the clinical need for effective therapies based on the severity of the COVID-19 pandemic in that country. Only 5.2% of trials have announced some form […]

Pharma

Global dry eye syndrome market to grow at 10.6% CAGR to reach $11.1bn in 2028, says GlobalData

The launch of new therapies between 2018 and 2028, including new classes of drugs with novel mechanisms of action (MOAs), and an anticipated increase in the prevalence of dry eye syndrome (DES) are expected to lead to an expansion of the global DES market says GlobalData, a leading data and analytics company. The company’s latest […]

Pharma

BeiGene’s commercialization experience will help it devise effective launch strategy for Brukinsa, says GlobalData

BeiGene has recently received approval for its second-generation Bruton’s tyrosine kinase (BTK) inhibitor Brukinsa (zanubrutinib) from the China National Medical Products Administration (NMPA). The China-based biotech firm’s experience of commercializing partner Celgene’s (now Bristol Myers Squibb) drugs will help in devising effective launch strategy for Brukinsa, says GlobalData, a leading data analytics and research company. […]

Pharma

Pharma increases sedative drug production for COVID-19 patients as FDA declare shortages

As the COVID-19 pandemic continues to sweep across the US, around 12% of intensive care hospitalized COVID-19 patients need to be placed on a ventilator. Not only does the procedure to do this require thousands of patients to be sedated, but they must also remain sedated if they have to stay on a ventilator longer-term. This […]

Pharma

Small market cap companies more dependent on COVID-19 pipeline drug, says GlobalData

The effects of the COVID-19 pandemic on the market capitalization (market cap) of companies are mitigated by having a COVID-19 drug in their pipeline, with the smaller cap companies being the worst-affected group. Perhaps, this trend is caused by the way the market caps of smaller companies are hinged on the expected success and demand […]

Pharma

Security and privacy concerns of telemedicine still need to be addressed, says GlobalData

The adoption of telemedicine has been accelerated significantly in the wake of COVID-19 outbreak. However, despite the increasing usage of the telehealth solutions, this innovation raises the same old questions related to security and privacy concerns, says GlobalData, a leading data and analytics company. Urte Jakimaviciute, Senior Director of Market Research at GlobalData, comments: “If […]

Pharma

COVID-19 vaccine immunity will require a concerted effort, says GlobalData

In order to achieve ‘herd immunity’ to COVID-19, there are estimates that anywhere from 50–90% of the population will need to achieve immunity. This will require a large amount of coordination and rapid deployment of vaccines to the general population, says GlobalData, a leading data and analytics company. Johanna Swanson, Product Manager at GlobalData, comments: […]

Pharma

Resurgence in the US and Europe will be bigger, harder to detect and harder to control, says GlobalData

Countries are beginning to reopen due to economic and social pressures, while keeping an eye on the threat of resurgences. Based on trends observed in Asia, GlobalData epidemiologists expect that there will be resurgences in the US and Europe. However, resurgence in the US and Europe will be bigger, harder to detect, and harder to […]

Pharma

Comorbidity a major concern in people with angina pectoris, says GlobalData

Comorbidity is a major concern in people with angina pectoris as, in 2019, there were nearly 20 million diagnosed prevalent cases of angina pectoris in the 7MM, according to GlobalData, a leading data and analytics company. More than 60% had one or more comorbidities, the most common of which was hypertension. Topias Lemetyinen, Managing Epidemiologist […]

Pharma

Myelodysplastic syndrome diagnosed incident cases set to reach 112,000 in 2028, says GlobalData

The burden of diagnosed myelodysplastic syndrome (MDS) is expected to increase at an annual growth rate (AGR) of 2.40% from around 90,000 cases in 2018 to 112,000 cases in 2028 in the eight major markets (8MM*), according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Myelodysplastic Syndrome: Epidemiology Forecast to 2028’, reveals […]

Pharma

COVID-19 deaths are being underreported, says GlobalData

COVID-19 deaths are most likely being underreported in the US, according to GlobalData, a leading data and analytics company. Excess deaths measure the difference between observed number of deaths and expected number of deaths. GlobalData calculates that there have been approximately 47,000 to 52,000 excess deaths since February 2, 2020. The causes of these excess […]

Pharma

GS-441524 could finally get trialed for feline infectious peritonitis in cats

Clinical trial results for Gilead Science’s remdesivir have shown modest improvement in the recovery of moderately ill COVID-19 patients and remdesivir’s success in humans could mean that GS-441524 will finally get trialed for feline infectious peritonitis (FIP) in cats, says GlobalData. Gilead Sciences published preliminary results from another Phase III study of its antiviral drug […]

Pharma

Technologies will help but not solve the emerging COVID-19 mental health crisis, says GlobalData

The COVID-19 pandemic presents significant growth opportunities for mental health and wellbeing technologies, however, telemedicine cannot replace in-person visits and these innovations will not resolve the upcoming crisis as it is novel and unprecedented, says GlobalData, a leading data and analytics company. Urte Jakimaviciute, MSc, Senior Director of Market Research, commented: “The pandemic is predicted […]

Pharma

Further research on MIS-C can provide insights on how COVID-19 affects immune system, says GlobalData

Some children have developed a severe inflammatory response due to COVID-19 infection that appears similar to Kawasaki disease. Doctors are referring to this response as pediatric multisystem inflammatory syndrome, or multisystem inflammatory syndrome in children (MIS-C). Although severe COVID-19 illness is less frequent in children, with about 3% of confirmed cases in the US in […]

Pharma

ALS Global Day reiterates the need for an elusive cure despite promising late-stage pipeline

The International Alliance of Amyotrophic Lateral Sclerosis (ALS)/ Motor Neuron Disease (MND) Associations, recognizes June 21 as the ALS Global Day. The goal of this yearly campaign is to promote global awareness and raise funds for ALS research activities. Sarah Elsayed, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view on […]

Pharma

Bio/Pharma companies with COVID-19 drug in pipeline had smaller Q1 market cap decrease, says GlobalData

Having a COVID-19 drug in a bio/pharma company’s pipeline resulted in a smaller decrease in market capitalization (market cap) during the first quarter (Q1) of 2020 compared to companies that did not have a COVID-19 drug in their plan. Bio/pharma companies with a COVID-19 drug in their pipeline declined in aggregate market cap by 5.8%, […]

Pharma

Acute myeloid leukemia market to reach $5.1bn by 2029 driven by novel agents and label expansions

The acute myeloid leukemia (AML) market is expected to grow from $1.4bn in 2019 to $5.1bn in 2029 across the eight major markets (8MM*) at a high compound annual growth rate (CAGR) of 13.6%, according to GlobalData, a leading data and analytics company. This growth will be driven by label expansions of the already successful […]

Pharma

Serum Institute of India will play pivotal role in development of COVID-19 vaccines, says GlobalData

Serum Institute of India (SII) is the world’s largest vaccine producer in terms of volume. SII is currently working on three candidates for COVID-19, including the testing of its recombinant-BCG vaccine in Phase 3 clinical trials at several locations across India. With these, SII continues to play a pivotal role in the development and commercialization […]

Prev 1 … 87 88 89 90 91 … 108 Next

Alzheimer’s disease market to reach $12.9bn in 2028 driven by launch of new pipeline agents

Favipiravir approval in India will benefit majority of COVID-19 patients, says GlobalData

European COVID-19 clinical trials primarily focused on repurposing available therapies, says GlobalData

Global dry eye syndrome market to grow at 10.6% CAGR to reach $11.1bn in 2028, says GlobalData

BeiGene’s commercialization experience will help it devise effective launch strategy for Brukinsa, says GlobalData

Pharma increases sedative drug production for COVID-19 patients as FDA declare shortages

Small market cap companies more dependent on COVID-19 pipeline drug, says GlobalData

Security and privacy concerns of telemedicine still need to be addressed, says GlobalData

COVID-19 vaccine immunity will require a concerted effort, says GlobalData

Resurgence in the US and Europe will be bigger, harder to detect and harder to control, says GlobalData

Comorbidity a major concern in people with angina pectoris, says GlobalData

Myelodysplastic syndrome diagnosed incident cases set to reach 112,000 in 2028, says GlobalData

COVID-19 deaths are being underreported, says GlobalData

GS-441524 could finally get trialed for feline infectious peritonitis in cats

Technologies will help but not solve the emerging COVID-19 mental health crisis, says GlobalData

Further research on MIS-C can provide insights on how COVID-19 affects immune system, says GlobalData

ALS Global Day reiterates the need for an elusive cure despite promising late-stage pipeline

Bio/Pharma companies with COVID-19 drug in pipeline had smaller Q1 market cap decrease, says GlobalData

Acute myeloid leukemia market to reach $5.1bn by 2029 driven by novel agents and label expansions

Serum Institute of India will play pivotal role in development of COVID-19 vaccines, says GlobalData

Browse

Company information